Related Experiment Video

Updated: Jan 2, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.0K

Predictive value of ATRIA risk score for contrast-induced nephropathy after percutaneous coronary intervention for

Fatih Aksoy1, Ali Bagcı2

  • 1MD, Associate Professor From the Department of Cardiology, Suleyman Demirel University, Medical School, Isparta, Turkey.

Revista Da Associacao Medica Brasileira (1992)
|December 5, 2019
PubMed

Insights

The ATRIA and CHA2DS2-VASC risk scores can effectively predict contrast-induced nephropathy (CIN) in acute myocardial infarction (AMI) patients undergoing percutaneous coronary intervention (PCI). These scores demonstrate utility in identifying patients at risk for CIN post-STEMI.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Risk Prediction

Background:

  • The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) risk score, initially for atrial fibrillation (AF) patients, shows potential in predicting outcomes for acute myocardial infarction (ACS) patients.
  • Contrast-induced nephropathy (CIN) is a significant complication following percutaneous coronary intervention (PCI) in ACS patients.

Purpose of the Study:

  • To analyze the relationship between risk scores and CIN development in ACS patients undergoing urgent PCI.
  • To compare the predictive ability of the ATRIA risk score against the MEHRAN risk score for CIN.

Main Methods:

  • Analysis of 429 patients with ST-segment Elevation Myocardial Infarction (STEMI) undergoing urgent PCI.
  • Comparison of clinical, laboratory, and demographic features between patients with and without CIN, including ATRIA and CHA2DS2-VASc risk scores.
  • Multivariate regression and Receiver Operating Characteristic (ROC) curve analysis to determine predictors and prognostic value for CIN.

Main Results:

  • ATRIA risk score, Opaque/Creatinine Clearance ratio, and low left ventricular ejection fraction were independent predictors of CIN.
  • C-statistics for ATRIA and CHA2DS2-VASC scores were 0.66 and 0.64, respectively, indicating significant predictive value.
  • Both ATRIA and CHA2DS2-VASC scores were not inferior to the MEHRAN score in predicting CIN.

Conclusions:

  • The ATRIA and CHA2DS2-VASC scoring systems are valuable tools for identifying CIN risk in STEMI patients post-PCI.
  • These established risk scores offer a practical approach to CIN risk stratification in this patient population.
Abstract

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

761
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.8K

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
173
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
315
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
657
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
335
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
921